This invention relates to novel compounds of the Formulae I or II and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD 1 in mammals. Formula (I).
该发明涉及公式I或II的新化合物及其药学上可接受的盐,以及这些化合物的药物组合物,可用于治疗与哺乳动物中11β-H
SD 1的调节或抑制有关的疾病。公式(I)。